| BCBS California | Autologous Platelet-Derived Growth Factors for Wound Healing and Other Non-Orthopedic Conditions | 2026-03-01 |
| BCBS California | Bariatric Surgery | 2026-03-01 |
| BCBS California | Biomarker Testing in Risk Assessment and Management of Cardiovascular Disease | 2026-03-01 |
| BCBS California | Bone Turnover Markers for Diagnosis and Management of Osteoporosis and Diseases Associated with High Bone Turnover | 2026-03-01 |
| BCBS California | Carrier Screening for Genetic Diseases | 2026-03-01 |
| UHC Surest Medical and Drug | Elevidys® (Delandistrogene Moxeparvovec-Rokl) - Commercial Medical Benefit Drug Policy | 2026-03-01 |
| UHC UMR Medical and Drug | Elevidys® (Delandistrogene Moxeparvovec-Rokl) - Commercial Medical Benefit Drug Policy | 2026-03-01 |
| UHC Commercial Medical & Drug | Elevidys® (Delandistrogene Moxeparvovec-Rokl) - Commercial Medical Benefit Drug Policy | 2026-03-01 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Site of Care | 2026-03-01 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Complement Inhibitors | 2026-03-01 |